Search Results
Search results for "Design Pharmaceuticals"
Results found for "Design Pharmaceuticals"
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical
- Elva Zhao: G Protein Regulation and Biased Signaling at the GLP-1 Receptor | Dr. GPCR Ecosystem
About the Guest Elva Zhao is a Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical Sciences
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
— Academic–industry collaborations in GPCR drug discovery Insights from collaborative research with pharmaceutical It also showed me how important GPCR research is in pharmaceutical development.
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
Other academic interests of his include studying pharmaceutical finance & healthcare administration and
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
lie at the interface of structural biology and drug discovery, where molecular structures inform the design I can imagine myself in a biotech or pharmaceutical environment where I’m helping guide drug development
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
what happens when taste pharmacology intersects with drug development - a collision that, for most of pharmaceutical
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine.
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
We help GPCR innovators design systems, strategies, and operating frameworks that drive predictable growth Our work helps biotech startups, research organizations, and CROs design operating systems that enable Core themes: Strategic Planning for Biotech Growth Operational System Design (OS) Cross-functional Team you’re leading a GPCR startup, a CRO, or an academic lab ready to scale, Timeline Strategy helps you design
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
The experiment that mattered most was not a drug candidate or a clinical advance - it was a designed Endosomal signaling is being missed Conventional GPCR assay design - stimulate, wash, measure endpoint Every positive and negative control performed exactly as designed. The conjugate worked. produced before - and it came directly from experience-built intuition rather than hypothesis-first design "I was convinced that I designed something that worked where it was not at all obvious that it was going
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Themes of the Conversation Silicon-based DNA synthesis and the end of degenerate oligos in library design Motif-directed library design — encoding ligand-binding sequences into CDR3 architecture The library Twist's silicon platform produces pools of discrete, designed sequences — a shift in how synthetic libraries The design decision is the library's main differentiator. A motif-directed library reaches targets its motifs weren't designed for.
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
dismissal is partly methodological and partly personal: the proudest moment of her scientific life was designing Nordisk, and into biotech at InterAx — where the next challenge is using functional fingerprints to design InterAx treats GPCR pharmacology the way engineers treat aircraft design: build the mathematical model Her most formative scientific moment was designing a compound in HEK293 cells from a hypothesis at Novo numbers miss what a ligand is really doing 16:40 — AI plus "real intelligence": functional data in drug design
- GPCR Webinars | Dr. GPCR Ecosystem
Topics Covered The biological basis of receptor signaling bias and ligand-dependent conformations How to design Every session is designed to move your science forward. First Dr. GPCR event? Welcome. They're designed for scientists who want deep, data-driven discussion rather than surface-level overviews These sessions are designed for interaction — scientists asking direct questions and getting real answers GPCR pharmacology, signaling, structural biology, allosteric modulation, biased agonism, assay design
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She has advanced the use of computational methods to meet the challenges of designing therapeutics with molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors and drug design
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
Now at the University of Glasgow, his primary research interests are focused on the rational design of at the University of Glasgow underpinned by a ÂŁ118M new build that will house over 550 researchers designed
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
The episode explores gpcr internalization , fluorescence-based probe design, and how functional assay academic tool development to real-world adoption Balancing innovation with validation in GPCR assay design By combining fluorophore design, ligand chemistry, and pharmacology, his work enables precise visualization
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
Bryan Roth on the DARPA-funded effort to design a non-psychedelic psychedelic for depression — and why effort his lab is leading to answer that question through structure-guided drug discovery, biased ligand design are biological, not chemical Polypharmacology for complex neuropsychiatric disease Functional assay design Roth argues, belongs to designed polypharmacology.
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
for twelve years, through the company's acquisition by Sosei, helping establish structure-based drug design Scientific Themes of the Conversation Structure-based GPCR drug design and the thermostabilization breakthrough membrane protein team from scratch 15:29 Unexpected allosteric pockets and the next wave of GPCR drug design her team made considerable breakthroughs in the field of GPCR stabilization and structure-based drug design
- Who We Are | Dr. GPCR Ecosystem
We designed the Ecosystem to support your work —no matter where you are in your GPCR journey. contributing behind-the-scenes tools and insight What Makes the Ecosystem Different Built for Drug Discovery Designed by scientists in the GPCR space to accelerate your research goals Collaborative by Design Connects researchers
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
GPCR — an ecosystem of podcasts, newsletters, summits, and working spaces designed to give the field Generate Biomedicines, where she worked on class B peptide receptor engineering using AI-driven protein design Scientific community as infrastructure — what connective tissue a 400-receptor field actually needs Assay design Building during a pandemic is a design constraint, not a footnote. Dr.
- Trademark Policy | Dr. GPCR Ecosystem
Discover our comprehensive Trademark Policy designed to protect the integrity and uniqueness of Dr. Buttons And Badges Guideline These guidelines provide you with the design specification for various Dr GPCR Logo in different marketing materials, such as a new T-shirt design, a toy, software packaging, These trademarks include the Logo, Buttons, Badges, Website Design, and other pictures and graphic designs
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
circuits — insights that inform next-generation functional assay development and translational therapeutic design changed our understanding of GPCR signaling in metabolic tissues What collaborative chemistry enabled in designing
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
the transmembrane bundle, and what class C GPCR architecture means for neurological disease and drug design opioid receptor by Kobilka, Gnäder, Roth, and Shokat as an illustration of what pathway-selective drug design pathway switching remains a viable and underexplored pharmacological strategy for GPCR-targeted drug design demonstrated 23:37 - What full-length structures in multiple states still need to deliver for drug design
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
He explains what chemical design can solve that antibodies can’t, how to validate functional assay systems Why this matters How a chemist with zero biology training became a leader in GPCR probe design.
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
With a deep focus on structure-based drug design, Jens discusses how his lab bridges simulation and experiment—and Outside academia, he advises companies through a consulting arm focused on ligand design strategy.
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
understand the mechanism and structural bases for ligand binding and efficacy to help optimize the design The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and
- University Pricing | Dr. GPCR Ecosystem
All these benefits are designed to enhance your research experience and keep you informed about the latest Members-only networking, AMAs & matchmaking đź’ˇ Support open resources for the global GPCR field đź§ Designed
- Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem
effect, physiological examples of the beta-arrestin-biased receptors pharmacologists have been trying to design neat bifurcation between G-protein and beta-arrestin signaling that drove early opioid receptor drug design Shukla's lab designed antibody fragments to stabilize GPCR–beta-arrestin complexes for structural studies
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
Jacobson, Matteo Pavan Structure-Based Design of Modulators of Purinergic GPCRs <p class="font_8">Watch Now</p> Terry Kenakin Designing with Time: GPCR Ligand Kinetics <p class="font_8">Watch Now</p> Andrew
- FAQ | Dr. GPCR Ecosystem
These webinars are designed for scientists who want deep, data-driven discussion rather than surface-level
























